MTOR and metabolic disease: Phosphoinositide 3-kinase (PI3K) and AKT, a serine/threonine protein kinase also known as protein kinase B, are key components with the mechanistic target of rapamycin (mTOR) for signaling network [17], possibly related to the pathogenesis of cardio-metabolic disorders.